
UNH
UnitedHealth Group Incorporated · NYSE
$512.60+0.97%
9 Sep close- Market cap
- $472B
- Sector
- Health care
Income statement
Revenue, costs and earnings
Loading

| Quarter | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | TTM | Trend |
|---|---|---|---|---|---|---|
| Period ending | 30 Sep 25 | 31 Dec 25 | 31 Mar 26 | 30 Jun 26 | 30 Jun 26 | Each line by period |
| Revenue | $107.1B | $113.5B | $109.3B | $112.8B | $442.8B | |
| Cost of revenue | −$82.9B | −$87.9B | −$85.5B | −$88.2B | −$344.5B | |
| Gross profit | $24.2B | $25.6B | $23.9B | $24.6B | $98.3B | |
| Operating costs | −$10.7B | −$11.3B | −$9.9B | −$10.2B | −$42.1B | |
| Cost of products sold | −$4.5B | −$4.7B | −$4.2B | −$4.3B | −$17.6B | |
| Depreciation and amortisation | −$2.1B | −$2.2B | −$1.9B | −$2.0B | −$8.1B | |
| Restructuring and other charges | −$0.4B | −$0.4B | −$1.1B | −$1.1B | −$3.0B | |
| Operating income | $6.6B | $7.0B | $6.8B | $7.1B | $27.4B | |
| Operating margin | 6.1% | 6.1% | 6.3% | 6.3% | 6.2% | |
| Other income and expense, net | −$0.4B | −$0.4B | −$0.5B | −$0.5B | −$1.8B | |
| Income before taxes | $6.2B | $6.5B | $6.4B | $6.6B | $25.7B | |
| Income tax expense | −$1.4B | −$1.5B | −$1.5B | −$1.5B | −$5.9B | |
| Net income | $4.8B | $5.0B | $4.9B | $5.0B | $19.8B | |
| Diluted shares, billions | 0.93 | 0.93 | 0.92 | 0.92 | 0.92 | |
| Diluted earnings per share | $5.13 | $5.44 | $5.34 | $5.49 | $21.49 | |
| Derived metrics | ||||||
| Revenue growth, period on period | no prior period | +6.0% | −3.7% | +3.1% | not comparable | |
| Gross margin | 22.6% | 22.6% | 21.8% | 21.8% | 22.2% | |
| Net margin | 4.5% | 4.4% | 4.5% | 4.5% | 4.5% | |
Billions of dollars, except earnings per share in dollars and the share count in billions. Growth is on the period before; the trailing twelve months is on the last full period.